• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Apr 2;14(1):7751.
doi: 10.1038/s41598-024-58113-8. Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland

Anssi Lipponen[SUP] 1 2 [/SUP], Aleksi Kolehmainen[SUP] 3 [/SUP], Sami Oikarinen[SUP] 4 [/SUP], Anna-Maria Hokajärvi[SUP] 3 [/SUP], Kirsi-Maarit Lehto[SUP] 4 [/SUP], Annamari Heikinheimo[SUP] 5 6 [/SUP], Jani Halkilahti[SUP] 7 [/SUP], Aapo Juutinen[SUP] 8 [/SUP], Oskari Luomala[SUP] 8 [/SUP], Teemu Smura[SUP] 9 [/SUP], Kirsi Liitsola[SUP] 7 [/SUP], Soile Blomqvist[SUP] 7 [/SUP], Carita Savolainen-Kopra[SUP] 7 [/SUP], Tarja Pitkänen[SUP] 3 5 [/SUP]; WastPan Study Group



Collaborators, Affiliations
Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants may have different characteristics, e.g., in transmission, mortality, and the effectiveness of vaccines, indicating the importance of variant detection at the population level. Wastewater-based surveillance of SARS-CoV-2 RNA fragments has been shown to be an effective way to monitor the COVID-19 pandemic at the population level. Wastewater is a complex sample matrix affected by environmental factors and PCR inhibitors, causing insufficient coverage in sequencing, for example. Subsequently, results where part of the genome does not have sufficient coverage are not uncommon. To identify variants and their proportions in wastewater over time, we utilized next-generation sequencing with the ARTIC Network's primer set and bioinformatics pipeline to evaluate the presence of variants in partial genome data. Based on the wastewater data from November 2021 to February 2022, the Delta variant was dominant until mid-December in Helsinki, Finland's capital, and thereafter in late December 2022 Omicron became the most common variant. At the same time, the Omicron variant of SARS-CoV-2 outcompeted the previous Delta variant in Finland in new COVID-19 cases. The SARS-CoV-2 variant findings from wastewater are in agreement with the variant information obtained from the patient samples when visually comparing trends in the sewerage network area. This indicates that the sequencing of wastewater is an effective way to monitor temporal and spatial trends of SARS-CoV-2 variants at the population level.


 
Back
Top Bottom